Barretts Esophagus With High Grade Dysplasia Clinical Trial
Official title:
Calcium Electroporation in Patients With Barrett's Esophagus High-grade Dysplasia
The aim of this first-in-man study is to evaluate the safety of calcium electroporation used in patients with Barrett's esophagus high-grade dysplasia through an endoscopic system.
After being informed about the study and potential risks, all patients give written informed consent. Thereafter, patient will get calcium electroporation with biopsies and digital photographs on day 0. We expect to discharge all patients same evening. Between day 3-7 an examination is followed by gastroscopy with biopsies and digital photographs. On day 14 the patients are followed in our outpatient clinic. 6 weeks after treatment the patients will undergo endoscopic mucosa resection (EMR) or endoscopic submucosa dissection (ESD) surgery and thereby the standard care of treatment for Barrett's esophagus high-grade dysplasia. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03240679 -
Endoscopic Mucosal Resection and Cellular Matrix
|
N/A | |
| Completed |
NCT06381583 -
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
|